The second insight: Radionuclide diagnosis

https://doi.org/10.1016/0146-5724(84)90074-8Get rights and content

Abstract

Nuclear medicine has been defined as the use of radionuclides (unsealed sources of radiation) in the diagnosis and treatment of disease. It is a predominantly diagnostic speciality. Of the two aspects of disease, disordered structure and disordered function, nuclear medicine or radionuclide diagnosis has been unique in consistently providing information about disordered function. The method has applications both in life (in vivo examinations, often involving imaging radionuclide distributions in the body) and in the test-tube (in vivo). The tracer principle has allowed insights in respect of both patient care and research across a broad spectrum of diseases. Although nuclear medicine is a specialty which continues to evolve, it already has an established role in health care, predicated on its ability to study function.

References (26)

  • G. Hevesy

    Biochemistry

    (1923)
  • M. Brucer

    The Heritage of Nuclear Medicine

    (1979)
  • R.S. Yalow et al.

    Nature

    (1959)
  • B. Cassen et al.

    Nucleonics

    (1951)
  • H.O. Anger

    Rev. Sci. Instr.

    (1958)
  • G. Muehllenhner et al.

    J. Nucl. Med.

    (1980)
  • R. Wicks et al.

    J. Nucl. Med.

    (1979)
  • A.Z. Cole et al.

    Phys. Med. Biol.

    (1982)
  • A. Todd-Pokropek

    IEEE Trans. Nucl. Sci.

    (1980)
  • M.L. Goris

    J. Nucl. Med.

    (1982)
  • B.Y. Croft
  • J.W. Keys

    J. Nucl. Med.

    (1982)
  • Cited by (1)

    View full text